Inventor · disambiguated record
B. Wesley Trotter
Also filed as: TROTTER B W · TROTTER B WESLEY
29 granted patents·5 pending applications·48 citations·filing 2003–2019
94Inventor score
Top patents by PatentIndex Score
34 records- 0192US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0285US10287272B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted May 14, 2019·3 cites·30 claims
- 0377US9682978B22,6,7 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 20, 2017·2 cites·10 claims
- 0477US8252799B2Hexahydro-1H-4,7-methanoisoindole-1,3-dione compoundsBILODEAU MARK T·Filed 2008·Granted Aug 28, 2012·2 cites·8 claims
- 0576US7879839B2Potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·2 cites·5 claims
- 0675US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 0775US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 0872US8389720B2Quinolone neuropeptide S receptor antagonistsBARROW JAMES C·Filed 2009·Granted Mar 5, 2013·1 cites·8 claims
- 0971US10344000B2Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·23 claims
- 1071US8410111B2Hexahydro-1H-4,7-methanoisoindole-1,3-dione compoundsBILODEAU MARK T·Filed 2012·Granted Apr 2, 2013·1 cites·8 claims
- 1170US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 1267US10689369B2Substituted indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2019·Granted Jun 23, 2020·0 cites·24 claims
- 1366US7723352B2Isoquinolinone potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted May 25, 2010·2 cites·8 claims
- 1465US9024032B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted May 5, 2015·1 cites·86 claims
- 1565US8541595B2Imidazoisoindole neuropeptide S receptor antagonistsMANLEY PETER J·Filed 2009·Granted Sep 24, 2013·1 cites·4 claims
- 1664US9309199B2Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disordersWOLKENBERG SCOTT·Filed 2011·Granted Apr 12, 2016·1 cites·16 claims
- 1762US7371754B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2003·Granted May 13, 2008·1 cites·4 claims
- 1860US9867821B2Hexahydro-1H-4,7-methanoisoindole-1,3-dione compoundsMERCK SHARP & DOHME·Filed 2013·Granted Jan 16, 2018·0 cites·15 claims
- 1958US7906521B2Quinazoline potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Mar 15, 2011·1 cites·11 claims
- 2056US2007173525A1Tyrosine kinase inhibitorsKIM ANNETTE·Filed 2007·Application pending·0 cites
- 2156US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 2251US2005239815A1Tyrosine kinase inhibitorsKIM ANNETTE J·Filed 2003·Application pending·0 cites
- 2347US7691879B2Isoquinoline potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Apr 6, 2010·0 cites·3 claims
- 2446US7569589B2Potassium channel inhibitorsMERCK & CO INC·Filed 2005·Granted Aug 4, 2009·0 cites·13 claims
- 2546US2009325936A1Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseasesBILODEAU MARK T·Filed 2007·Application pending·0 cites
- 2646US2010099673A1Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseasesBILODEAU MARK T·Filed 2008·Application pending·0 cites
- 2745US10584121B2Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 10, 2020·0 cites·23 claims
- 2845US8030332B2Potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Oct 4, 2011·0 cites·4 claims
- 2944US9637493B2Substituted pyrrolopyrimidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 2, 2017·0 cites·15 claims
- 3043US7763614B2Isoquinoline potassium channel inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Jul 27, 2010·0 cites·7 claims
- 3142US8338449B2Isoquinolinone potassium channel inhibitorsTROTTER B WESLEY·Filed 2010·Granted Dec 25, 2012·0 cites·17 claims
- 3242US8080543B2Pyridine derivative potassium channel inhibitorsTROTTER B WESLEY·Filed 2007·Granted Dec 20, 2011·0 cites·10 claims
- 3341US8148535B2Potassium channel inhibitorsTROTTER B WESLEY·Filed 2006·Granted Apr 3, 2012·0 cites·8 claims
- 3440US8278317B2Potassium channel inhibitorsTROTTER B WESLEY·Filed 2006·Granted Oct 2, 2012·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →